SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients

Introduction

Acute adrenal insufficiency, also termed adrenal crisis, is a life-threatening endocrine emergency brought about by a lack of production of the adrenal hormone cortisol, the major glucocorticoid. Identifying patients at risk and prompt management can save lives. This guideline aims to take the non-specialist through the initial phase of assessment and management.

Underlying conditions

Primary adrenal insufficiency is caused by loss of function of the adrenal gland itself, for example due to autoimmune-mediated destruction of adrenocortical tissue or surgical removal of the adrenal glands or due to inborn disruption of adrenal cortisol production in congenital adrenal hyperplasia.

Secondary adrenal insufficiency is caused if the regulation of adrenal cortisol production by the pituitary is compromised, this can be the consequence of tumours in the hypothalamic–pituitary area. However, pituitary regulation of cortisol production is also switched off in patients who receive chronic exogenous glucocorticoid treatment with doses ≥5 mg prednisolone equivalent for more than 4 weeks. This may also be caused by long-lasting glucocorticoid injections into joints or chronic application of glucocorticoid cream or inhalers.

In primary adrenal insufficiency cortisol deficiency is aggravated by a lack of adrenal aldosterone production, a hormone important for blood pressure and electrolyte regulation. This puts primary adrenal insufficiency patients at a somewhat higher risk of adrenal crisis.

Clinical presentation

Clinical signs and symptoms:

• Fatigue, lack of energy, weight loss

• Low blood pressure, postural dizziness and hypotension (≥20 mmHg drop in BP from supine to standing position), dizziness, collapse, in severe cases hypovolaemic shock

• Abdominal pain, tenderness and guarding, nausea, vomiting (in particular in primary adrenal insufficiency), history of weight loss

• Fever

• Confusion, somnolence, in severe cases delirium or coma

• Back and leg cramps/spasms are commonly reported and can be distracting if not recognised for what they are (electrolyte derangement in large muscles?)

• In primary adrenal insufficiency: generalised skin hyperpigmentation, in particular in areas exposed to mechanical shear stress (palmar creases, nipples, scars, inside of oral mucosa)

• In secondary adrenal insufficiency: alabaster-like, pale skin; dependent on underlying conditions also signs and symptoms of other pituitary axis deficiencies

Lab findings:

• Hyponatraemia (in primary and secondary adrenal insufficiency)

• Hyperkalaemia (in primary adrenal insufficiency)

• Pre-renal failure (increased serum creatinine due to hypovolaemia)

• Normochromic anaemia, sometimes also lymphocytosis and eosinophilia

• Hypoglycaemia (primarily in affected children; can cause long-term neurological deficits, if not promptly treated)

Investigations for suspected adrenal crisis in patients not already known to have adrenal failure

• Adrenal insufficiency should be ruled out in any acutely ill patient with signs or symptoms potentially suggestive of acute adrenal insufficiency

• Assess blood pressure and fluid balance status; if clinically feasible, measure blood pressure from supine to standing to check for postural drop

• Take drug history (glucocorticoids?)

• Bloods:

• Diagnostic measures should never delay prompt treatment of a suspected adrenal crisis! There are no adverse consequences of initiating life-saving hydrocortisone treatment and diagnosis can be safely and formally established once the patient has clinically recovered

• If the patient is haemodynamically stable, consider performing a short Synacthen test (serum cortisol at baseline and 30 min after i.v. injection of 250 micrograms ACTH_1–24); however, if the patient is severely ill, confirmation of diagnosis can be safely left until after clinical recovery following implementation of emergency dose hydrocortisone treatment

• Serum/plasma aldosterone and plasma renin (aldo­sterone will be low and renin high in primary adrenal insufficiency; observe special sample collection and transport conditions; can be left to confirmation of diagnosis after clinical recovery)

Management of adrenal crisis

• Hydrocortisone (immediate bolus injection of 100 mg hydrocortisone i.v. or i.m. followed by continuous intravenous infusion of 200 mg hydrocortisone per 24 h (alternatively 50 mg hydrocortisone per i.v. or i.m. Injection every 6 h)

• Rehydration with rapid intravenous infusion of 1000 mL of isotonic saline infusion within the first hour, followed by further intravenous rehydration as required (usually 4–6 L in 24 h; monitor for fluid overload in case of renal impairment and in elderly patients)

• Contact an endocrinologist for urgent review of the patient, advice on further tapering of hydrocortisone, investigation of the underlying cause of disease including diagnosis of primary vs secondary adrenal insufficiency

• Tapering of hydrocortisone can be started after clinical recovery guided by an endocrinologist. In patients with primary adrenal insufficiency, mineralocorticoid replacement needs to be initiated (starting dose 100 micrograms fludrocortisone once daily) as soon as the daily glucocorticoid dose is below 50 mg hydrocortisone/24 h

Precipitating factors

• In more than half of patients with adrenal insufficiency the diagnosis of adrenal failure is only established after presentation with an acute adrenal crisis

• However, patients with established adrenal insufficiency and those receiving chronic exogenous supraphysiological glucocorticoid treatment (e.g. for asthma or autoimmune disease) are at permanent risk of adrenal crisis. Most frequent causes are:

After emergency care: how to prevent an adrenal crisis

• Regular review of the patient by an endocrinologist, initially monthly, in the long-term every 6–12 months

• Education of patients and partner/parents regarding symptom awareness and the correct adjustment of glucocorticoid replacement dose:

• Provide the patient with a Steroid Emergency Card www.endocrinology.org/adrenal-crisis and encourage them to wear medical alert bracelets, in addition to keeping the steroid emergency card with them at all times and showing it to any health care professional they are dealing with

• Provide them with emergency phone numbers and contact details for the patient self-help groups

Further information

For further information and to request a steroid card, please go to the Society for Endocrinology’s website www.endocrinology.org/adrenal-crisis.

Disclaimer

The document should be considered as a guideline only; it is not intended to determine an absolute standard of medical care. The doctors concerned must make the management plan for an individual patient.